|
BioTime Announces Second Quarter 2014 Results and Recent Developments
Wall Street Journal In addition, BioTime’s subsidiary Asterias received $12.5 million in June 2014 through the sale of 5,000,000 BioTime common shares, with warrants to purchase 5,000,000 shares of Asterias Series B common stock, to two private investors who are long-term … |
